pharma news today obesity glp-1 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Patient Behavior: How Does Price

[4] Understanding this pharmacological basis helps patients recognise that bloating, whilst uncomfortable, is a predictable consequence of how these medications work rather than an indication of treatment failure

We offer in-house lab testing that establishes your hormone levels and key biomarkers before any treatment decision is made

Diabetologia 60 (12), 24752485 (2017)

This ensures verified purity (99%+), safety, and consistency, with Certificates of Analysis available for transparency

This study describes a novel biochemical mechanism by which glutathione deficiency causes epigenetic impairment of vitamin D metabolism gene in the liver and its contribution to reduced circulating levels of 25(OH)VD 3 in HFD-fed obese mice

speaking fees from Liva-Nova, Johnson and Johnson (Janssen)